Maximilian Merz

机构：Memorial Sloan Kettering Cancer Center, Kettering University · ORCID：0000-0001-8513-4240

发表论文 76 篇 · 总被引 1193 次 · h-index 19

代表论文

• EASIX for prediction of survival in lower-risk myelodysplastic syndromes (2019 · Blood Cancer Journal · 被引 72)
• Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial (2020 · Leukemia · 被引 67)
• Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma (2019 · Leukemia · 被引 33)
• The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs) (2021 · EJNMMI Research · 被引 32)
• Front-Line Daratumumab-VTd Versus Standard-of-Care in ASCT-Eligible Multiple Myeloma: Matching-Adjusted Indirect Comparison (2020 · Immunotherapy · 被引 18)
• Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria (2020 · Cancers · 被引 14)